Cargando…
Copeptin, IGFBP-1, and Cardiovascular Prognosis in Patients With Type 2 Diabetes and Acute Myocardial Infarction: A report from the DIGAMI 2 trial
OBJECTIVE: To determine whether C-terminal provasopressin (copeptin) explains the prognostic importance of insulin growth factor binding protein-1 (IGFBP-1) in patients with myocardial infarction and type 2 diabetes. RESEARCH DESIGN AND METHODS: Copeptin and IGFBP-1 were analyzed in 393 patients par...
Autores principales: | Mellbin, Linda G., Rydén, Lars, Brismar, Kerstin, Morgenthaler, Nils G., Öhrvik, John, Catrina, Sergiu B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890367/ https://www.ncbi.nlm.nih.gov/pubmed/20413521 http://dx.doi.org/10.2337/dc10-0088 |
Ejemplares similares
-
Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial
por: Mellbin, L.G., et al.
Publicado: (2010) -
Complement Activation and Prognosis in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial
por: Mellbin, Linda G., et al.
Publicado: (2012) -
Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction
por: Wang, Anne, et al.
Publicado: (2021) -
Copeptin—Marker of Acute Myocardial Infarction
por: Möckel, Martin, et al.
Publicado: (2014) -
The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department
por: Nickel, Christian H, et al.
Publicado: (2012)